PTC THERAPEUTICS, INC. — Director's Dealing 2014

Sep 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-09-24

Reporting Person: Rothera Mark (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-24	Common Stock	M	900	$10.85	Acquired	17900	Direct
2014-09-24	Common Stock	S	900	$43.86	Disposed	17000	Direct
2014-09-24	Common Stock	S	2000	$42.88	Disposed	15000	Direct
2014-09-25	Common Stock	M	4099	$10.85	Acquired	19099	Direct
2014-09-25	Common Stock	M	3001	$10.85	Acquired	22100	Direct
2014-09-25	Common Stock	S	7100	$44.15	Disposed	15000	Direct
2014-09-25	Common Stock	S	3000	$44.92	Disposed	12000	Direct
2014-09-26	Common Stock	S	3000	$46.90	Disposed	9000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-24	Stock Option (Right To Buy)	$10.85	M	900	Disposed	2023-05-15	Common Stock (900)	Direct
2014-09-25	Stock Option (Right To Buy)	$10.85	M	4099	Disposed	2023-05-15	Common Stock (4099)	Direct
2014-09-25	Stock Option (Right To Buy)	$10.85	M	3001	Disposed	2023-05-15	Common Stock (3001)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 21, 2013, as amended on March 17, 2014 and August 12, 2014.

F2: This option was granted on May 15, 2013. 25% of the grant vested on December 31, 2013. The remainder vests as to 1/48 of the shares underlying such option each month until December 2016.

F3: This option was granted on May 15, 2013. 25% of the grant vested on May 15, 2014. The remainder vests as to 1/48 of the shares underlying such option each month until May 2017.

F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.85 to $43.89 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $42.85 to $42.94 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.85 to $44.38 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F7: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $44.85 to $45.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F8: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.85 to $46.93 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.